GlaxoSmithKline Pharmaceuticals informs about board meeting

31 Dec 2018 Evaluate

Pursuant to clause 33 of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on Monday, 4th February, 2019, to consider and approve Un-Audited Financial Results for the quarter and nine months ended 31st December, 2018.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2371.20 -65.05 (-2.67%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.